I read somewhere--probably one of the PRs--that patients

New Post Public Reply Private Reply Replies (1) Message Board
sherlock57 weasel667 #158604
2,572
I read somewhere--probably one of the PRs--that patients didn't have to take the ICI concurrently with leronlimab to gain a benefit... What was important was that patients received LL first, it changed the tumor microenvironment and raised PD-L1 levels, and then the ICI could go to work on the inflamed tumors. Instead of trying to track down the citation, let me refer you to something more recent--Dr Lalezari's comments in the Karen Jagoda interview about "timelines." (Thanks KenChowder for cutting and pasting the transcript here on IH).

Jay Lalezari: "Well, we do not know a lot about the timelines. The one patient who's a long-term survivor and has been on leronlimab and a checkpoint inhibitor called atezolizumab for five years, the other four were on leronlimab for a period of time, then on a checkpoint inhibitor for a period of time."

These are the Ladies Dr J is talking about, with four out of the five having stopped leronlimab for an unknown period of time before receiving an ICI. So when you say "I guess dropping out of the trial (= no more leronlimab) would turn the hot tumor to a cold tumor again," well, that was an incorrect guess. What you described as a "suicidal move" turned out to be part of the process that saved their lives... because apparently a hot tumor stays hot. Hot enough for the ICI to work.

There is a lot we don't know about leronlimab and ICIs. Lalezari continued on in the interview to say "So we don't know what the timelines are of how long either drug would be required, and that's going to require the clinical studies to show us whether long-term maintenance is required or not." But at this stage of the game we do know leronlimab first, followed by an ICI... can save lives.

Our current trial is open label, and that implies patients are going to know what drugs and dose they are getting, as well as relevant CTC and PD-L1 numbers. If you are progressing on leronlimab but your PD-L1 numbers are up, wouldn't you drop out of the trial to get an ICI, if there are no provisions in the trial to give people the option?

I am hopeful for a clean, well-run clinical trial with few dropouts and good compliance from motivated patients. If the FDA decides not offer an ICI as part of the trial--after PD-L1 upregulation and upon progression--then I would expect many dropouts. Patients confronting life-and-death decisions, with all the stress and consternation that comes with those decisions. And less chance for the "unassailable" data we all seek. So the stakes are really huge for Cytodyn in this upcoming meeting... And they are huge for the FDA, too... for that matter. Not to mention they owe us one for the severe covid debacle...

I don't really have a clue how the FDA will decide this. It does occur to me that a future trial in first-line mCRC--with leronlimab and the SOC--would be a more appropriate venue to show off what leronlimab could do without being paired with an ICI right away... So FDA--make us do that kind of trial! Please!! But for this current trial with 3rd-line patients... no question in my mind they should get the ICI as soon as their PD-L1 numbers show they could benefit. And that is pretty much standard practice now, to give people ICI's when their PD-L1 numbers reach a certain level. So approving an ICI in this trial would be consistent with clinical practice. Let's freaking hope they do the right thing here...

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

VIGGO’s Mix1Pro Tests Practical Commercial Cleaning

Updated Category News Views 81

A cleaning robot earns its keep in the ugly corners, not under convention-center lights. VIGGO used the ISSA Show North America gathering in Las Vegas, held November 17–19, 2026, to introduce the Mix1Pro, a compact commercial machine aimed at indoor facilities below 53,800 square feet. That target matters. Smaller, messier sites are where autonomy can look terrific on a...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
SHEIN's EU Training Push Targets Seller Compliance Gaps

Updated Category News Views 102

Chemicals buried in a cheap handbag or kids' accessory can wreck a marketplace's credibility faster than any glossy campaign can repair it. That is the uncomfortable backdrop to SHEIN and SPEAC's November 19 session on EU chemical-safety rules for marketplace sellers. This was not a fashion trend webinar; it was a practical warning about high-risk substances, regulatory...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 107

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 35

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Trade Secret Damages Turn on Corporate Intent Evidence

Updated Category News Views 101

Suspicion may rattle a courtroom, but it apparently does not always loosen the jury’s purse strings. That is the useful, slightly sobering takeaway from DOAR’s new national study on damages in trade secret disputes, released November 20, 2026. Jurors, according to the report, draw a meaningful line between an employee carrying experience to a new job and a company...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 34

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading

Top 5 Most Recently Viewed Articles

Duke Robotics Unveils 2025 Insulator Cleaning Initiatives

Updated Category News Views 216

Exciting New Developments at Duke Robotics Duke Robotics Corp. (OTCQB: DUKR) has taken significant strides in the field of advanced robotics and autonomous drone technology. Recently, the company announced its 2025 insulator cleaning operations with the Israel Electric Corporation. This initiative marks an expansion of their innovative IC Drone system during the insulator...

Continue Reading
Understanding Chargebacks: Impact on Merchants and Solutions

Updated Category News Views 232

Unpacking the Chargeback Challenge for Online Businesses Chargebacks stand as a significant concern for many online businesses, especially as recent research reveals a startling statistic: up to 80 percent of chargebacks may be classified as abusive. As the world shifts increasingly towards e-commerce, platforms such as Chargeflow are stepping up to address these issues,...

Continue Reading
Exploration of the Reusable Transport Packaging Landscape 2025-2035

Updated Category News Views 203

The Reusable Transport Packaging Market Overview The global reusable transport packaging market was valued at USD 119.84 billion in recent evaluations and is projected to experience substantial growth, reaching USD 199.74 billion in the near future. This shift is propelled by increasing economic and environmental awareness as businesses look for sustainable packaging...

Continue Reading
Exploring TechnipFMC's Resilience in Offshore Energy Trends

Updated Category News Views 142

Understanding TechnipFMC's Current Position in the Market TechnipFMC plc (NYSE: FTI), a prominent name in the offshore energy sector, has been maneuvering through a challenging landscape in 2024. While the year began slower than anticipated, analysts maintain a positive outlook regarding the company’s future potential. This analysis will explore TechnipFMC's current...

Continue Reading
Cupshe Unveils 'Limitless' Campaign to Empower Women Everywhere

Updated Category News Views 400

Cupshe Introduces the Limitless Campaign The renowned fashion e-tailer Cupshe is excited to announce its new initiative, the Limitless campaign. This campaign is all about celebrating individuality and empowering women across the globe to embrace their true selves. The essence of the campaign focuses on body positivity and inclusivity, shining a spotlight on real women...

Continue Reading